| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 09/06/2007 | US20070208166 Tao Kinase Modulators And Method Of Use |
| 09/06/2007 | US20070208070 2-thioxo-4-imidazolines; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 09/06/2007 | US20070208064 Ion channel modulators |
| 09/06/2007 | US20070208059 Therapeutic Agents |
| 09/06/2007 | US20070208056 Piperidinyl derivatives as modulators of chemokine receptor activity |
| 09/06/2007 | US20070208049 e.g. 1-(2,6-Difluorobenzyl)-5-(3-Mehthoxyphenyl)-6-Methyl-3-[N-Methyl -N -(2-Pyridylethyl)Aminoethyl]Uracil; anticarcinoganic agent; prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 09/06/2007 | US20070208048 New Aryl Imidazoles and Related Compounds as C5a Receptor Modulators |
| 09/06/2007 | US20070208046 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders |
| 09/06/2007 | US20070208044 Compounds and therapeutical use thereof |
| 09/06/2007 | US20070208037 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines |
| 09/06/2007 | US20070208036 Arylalkanes, arylalkenes and aryl-azaalkanes, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/06/2007 | US20070208033 Amine compound and use thereof |
| 09/06/2007 | US20070208026 N-Containing Heteroaromatic Compounds As Modulators Of Ppars And Methods Of Treating Metabolic Disorders |
| 09/06/2007 | US20070208025 Novel pyridazine derivatives and medicines containing the same as effective ingredients |
| 09/06/2007 | US20070208024 (3-Fluoro-4'-methanesulfonyl-biphenyl-4-yl)-[2-(S)-(2-(R)-methyl-pyrrolidin-1-ylmethyl)-pyrrolidin-1-yl]-methanone; treatment of obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases |
| 09/06/2007 | US20070208019 Vasculostatic agents and methods of use thereof |
| 09/06/2007 | US20070208018 Quinazoline Derivatives |
| 09/06/2007 | US20070208008 Substituted sulfonamides and ureas useful for inhibiting kinase activity |
| 09/06/2007 | US20070208007 Amine-Based Compound and Use Thereof |
| 09/06/2007 | US20070208005 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h3 receptor |
| 09/06/2007 | US20070207991 Substituted N-aryl Heterocycles, Process For Their Preparation and Their Use As Medicaments |
| 09/06/2007 | US20070207331 Azo compounds and coating compositions containing the azo compounds |
| 09/06/2007 | DE102006009928A1 Substituierte Arylsulfonamide Substituted aryl sulfonamides |
| 09/05/2007 | EP1829871A1 Organic compound, charge-transporting material, and organic electroluminescent element |
| 09/05/2007 | EP1829870A1 2-(pyrazol-1-yl)pyridine derivative |
| 09/05/2007 | EP1829863A1 Arylalkanoic acid derivative |
| 09/05/2007 | EP1829862A1 Sigma receptor compounds |
| 09/05/2007 | EP1829861A2 Pyrrolidine ester derivatives active as oxytocin antagonists |
| 09/05/2007 | EP1828176A1 Tetrahydroquinoline analogues as muscarinic agonists |
| 09/05/2007 | EP1828172A1 Pyrrole derivatives having crth2 receptor antagonist activity |
| 09/05/2007 | EP1828168A2 Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
| 09/05/2007 | EP1828167A2 Acrylamide derivatives as antibiotic agents |
| 09/05/2007 | EP1828166A1 Hydantoin derivatives useful as metalloproteinase inhibitors |
| 09/05/2007 | EP1828165A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 09/05/2007 | EP1828164A1 Method for preparing n-phenylpyrazole-1-carboxamides |
| 09/05/2007 | EP1828163A2 Azole derivatives with antimuscarinic activity |
| 09/05/2007 | EP1828162A1 Tetrazolyl-methylene amino acid derivatives |
| 09/05/2007 | EP1828147A1 Quinoxalines as b-raf inhibitors |
| 09/05/2007 | EP1828146A1 Substituted n-heterocyclic compounds and their use as dopamine d3 receptor ligands |
| 09/05/2007 | EP1828144A2 Integrin antagonists useful as anticancer agents |
| 09/05/2007 | EP1828143A1 2-(phenyl or heterocyclic)-1h-phenantrho[9,10-d]imidazoles as mpges-1 inhibitors |
| 09/05/2007 | EP1828135A2 Compounds and compositions as modulators of steroidal receptors and calcium channel activities |
| 09/05/2007 | EP1828127A2 INSECTICIDAL BIS(SUBSTITUTED PHENYL)-1-äÝ4-(SATURATED HETEROCYCLYL-SUBSTITUTED)PHENYLMETHYL¨-(4-PIPERIDYL)üMETHANE DERIVATIVES |
| 09/05/2007 | EP1828123A1 Indolinones and their use as antiproliferative agents |
| 09/05/2007 | EP1828122A2 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenalin re-uptake inhibitors |
| 09/05/2007 | EP1827439A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 09/05/2007 | EP1827434A2 Quinolines and quinazoline analogs and their use as medicaments for treating cancer |
| 09/05/2007 | EP1827429A2 Pharmaceutical compositions comprising amorphous benzimidazole compounds |
| 09/05/2007 | EP1730116B1 4-carbox pyrazole derivates useful as anti-viral agents |
| 09/05/2007 | EP1633715B1 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists |
| 09/05/2007 | EP1618094B1 Substituted heteroaryls as inhibitors of protein tyrosine phosphatases |
| 09/05/2007 | EP1569638B1 Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders |
| 09/05/2007 | EP1474419B1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 09/05/2007 | EP1441724B1 Methods of increasing endogenous testosterone levels |
| 09/05/2007 | EP1406892B1 Phenyl pyrazole derivatives as soluble epoxide hydrolase inhibitors |
| 09/05/2007 | EP1373233B1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 09/05/2007 | EP1336611B1 Dehalogeno compounds |
| 09/05/2007 | EP1197492B1 Pyrazole derivatives and process for producing the same, and pesticides containing the same as the active ingredient |
| 09/05/2007 | EP1057815B1 Cyclic amide compounds |
| 09/05/2007 | EP0993452B1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 09/05/2007 | CN101031567A Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof |
| 09/05/2007 | CN101031561A Carbonyl compounds used as coagulation factor xa inhibitor |
| 09/05/2007 | CN101031560A Cyclic diaryl ureas suitable as tyrosine kinase inhibitors |
| 09/05/2007 | CN101031559A Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 09/05/2007 | CN101031558A HIV inhibiting 5-heterocyclyl pyrimidines |
| 09/05/2007 | CN101031557A Substituted quinolones |
| 09/05/2007 | CN101031550A HIV inhibiting 5-carbo- or heterocyclic substituted pyrimidines |
| 09/05/2007 | CN101031539A Substituted arylalkanoic acid derivatives and use thereof |
| 09/05/2007 | CN101029045A Method for preparing 4-(3-pyridyl)-1 H-imidazole-1-butyl amine |
| 09/05/2007 | CN101029044A Method for preparing 3-(imidazole-4) pyridine |
| 09/05/2007 | CN101029043A Aspartic acid laumosaren hydrate, its production and use |
| 09/05/2007 | CN101029042A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 09/05/2007 | CN101029022A Process for the preparation of 4-phenoxy quinoline derivatives |
| 09/05/2007 | CN100335478C Chemokine receptor binding heterocyclic compounds |
| 09/05/2007 | CN100335477C Pyrazolecarboxamide insecticides |
| 09/05/2007 | CN100335464C Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 09/04/2007 | US7265378 Light emitting diodes |
| 09/04/2007 | US7265227 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 09/04/2007 | US7265226 Interact with opoid receptors; decreasing metabolic rates of the phenolic piperidines by amidation, imidation, or forming a formamide, a hydroxyamidine or a thioamide; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction |
| 09/04/2007 | US7265144 Mixture with other active materials; controlling glucose metabolism |
| 09/04/2007 | US7265135 Antihistamines; cognition activators; Alzheimer's disease; antiepileptic agents; eating disorders; motion sickness; psychological disorders |
| 09/04/2007 | US7265134 Tyrosine kinase inhibitors |
| 09/04/2007 | US7265133 Biphenylylaminocarbonyl-amino- or -oxypiperidine derivatives, e.g., biphenyl-2-ylcarbamic acid 1-[2-({4-[(4-hydroxybenzylamino)methyl]benzoyl}methylamino)ethyl]piperidin-4-yl ester; treating bronchodilation and COPD |
| 09/04/2007 | US7265132 Peptidyl spiroheterocyclic, amidino and guanidino compounds; reversible inhibitors of the cysteine protease cathepsin S, K, F, L and B; useful in the treatment of autoimmune and other related diseases |
| 09/04/2007 | US7265129 Anti-infective biaryl compounds |
| 09/04/2007 | US7265125 4-Heteroaminoquinazoline derivatives,.e.g., 2-methyl-4-piperidin-1-yl-7-pyridin-3-yl-quinazoline; prophylaxis or treatment of arthritis, cardiovascular diseases, diabetes, renal failure and particularly eating disorders and obesity. |
| 09/04/2007 | US7265122 Pyridine, pyrimidine, quinoline, quinazoline, and naphthalene urotensin-II receptor antagonists |
| 09/04/2007 | US7265121 Chemical compounds |
| 09/04/2007 | US7265120 Pyrazine derivatives and pharmaceutical use thereof |
| 09/04/2007 | US7265116 Attention deficit disorders; hyperactivity; post-trauma stress disorders; anxiolytic agents; obsessive compulsive disorders; analgesics; Parkinson's disease |
| 09/04/2007 | US7265114 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
| 09/04/2007 | US7265112 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 09/04/2007 | US7265108 For example, 6-[2-[4-(2-fluorophenoxymethyl)piperidino]ethyl]-1H-pyrazin-2-one; therapeutic or prophylactic agent for diabetic neuralgia, HIV neuralgia, postherpetic neuralgia, nerve system disorders |
| 09/04/2007 | US7265102 Substituted pyrazoles |
| 09/04/2007 | CA2297911C Substituted 6-phenylphenanthridines |
| 09/04/2007 | CA2274063C Substituted pyrimidine compounds and their use |
| 09/04/2007 | CA2258044C Muscarinic antagonists |
| 09/04/2007 | CA2239174C Novel compounds with analgesic effect |
| 09/04/2007 | CA2232450C Oral pharmaceutical composition containing antimicrobial actives and sustained release pantoprazole |
| 08/30/2007 | WO2007098418A1 Compounds having 5-ht6 receptor affinity |